Nicotinic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00627 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 31 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | homozygous familial hypercholesterolemia | KG + DL |
| 2 | hyperlipoproteinemia | KG + DL |
| 3 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | KG + DL |
| 4 | familial hypercholesterolemia | KG + DL |
| 5 | cholesterol-ester transfer protein deficiency | KG + DL |
| 6 | hyperlipidemia due to hepatic triglyceride lipase deficiency | KG + DL |
| 7 | hypercholesterolemia, autosomal dominant | KG + DL |
| 8 | fibroma of prostate | KG + DL |
| 9 | benign reproductive system neoplasm | KG + DL |
| 10 | glaucoma | KG + DL |
| 11 | Brenner tumor | KG + DL |
| 12 | benign prostate phyllodes tumor | KG + DL |
| 13 | male reproductive organ cancer | KG + DL |
| 14 | prostate cancer/brain cancer susceptibility | KG + DL |
| 15 | HIV infectious disease | KG + DL |
| 16 | idiopathic copper-associated cirrhosis | KG + DL |
| 17 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 18 | primitive portal vein thrombosis | KG + DL |
| 19 | hepatoportal sclerosis | KG + DL |
| 20 | hepatopulmonary syndrome | KG + DL |
| 21 | hepatic porphyria | KG + DL |
| 22 | primary hereditary glaucoma | KG + DL |
| 23 | hypolipoproteinemia (disease) | KG + DL |
| 24 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 25 | prostate leiomyoma | KG + DL |
| 26 | female breast carcinoma | KG + DL |
| 27 | feline acquired immunodeficiency syndrome | KG + DL |
| 28 | simian immunodeficiency virus infection | KG + DL |
| 29 | hyperalphalipoproteinemia | KG + DL |
| 30 | open-angle glaucoma | KG + DL |
| 31 | prostate neoplasm | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.